CSOP FTSE China A50 Index Daily (2X) Leveraged Product (ticker: 7248.HK) and CSOP FTSE China A50 Index Daily (-1X) Inverse Product (ticker: 7348.HK) to List on the HKEXHONG KONG, Jan 19 (Bernama-BUSINESS WIRE) -- Hong Kong’s largest leveraged and inverse products (L&I products) issuer
1, CSOP Asset Management Limited (“CSOP”) is proud to announce the listing of the CSOP FTSE China A50 Index Daily (2X) Leveraged Product (ticker: 7248.HK) and the CSOP FTSE China A50 Index Daily (-1X) Inverse Product (ticker: 7348.HK) on the Hong Kong Stock Exchange on 20 January, 2021. 7248. HK and 7348.HK will apply a swap-based synthetic replication strategy to achieve the respective investment objectives. 7248.HK will provide investment results closely corresponding to twice (2x) the daily performance of the FTSE China A50 Index while 7348.HK will provide investment results closely corresponding to inverse (-1x) daily performance of the FTSE China A50 Index, both excluding costs and expenses. With listing prices around HKD 7.75 and trading lot size of 100, the entry investments of 7248.HK and 7348.HK are approximately HKD 775 respectively.
This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20210118005562/en/ Following the CSI300 leveraged & inverse products launched in last July, 7248.HK and 7348.HK provide more choices for investors who intended to gain short-term China A-shares exposures, especially to the big blue chips. Extensively tracked by a large scale of financial products and instruments in China overseas market, FTSE China A50 index investing in the 50 largest China A-shares was long known as one of the most representative China A-shares indices to international investors because of its sound index ecosystem. The ETF tracking FTSE China A50 index in Hong Kong is more than HKD 30 billion,
2 while the average daily turnover of FTSE China A50 futures listed on SGX is 297,270 lots.
3 The launch of the FTSE China A50 Index tracking L&I products will not only enrich the product offerings around FTSE China A50 Index but also provide investors, especially China A50 investors, with tools to amplify or hedge in an easy way.
Ms. Ding Chen, CEO of CSOP commented, “It has been almost 9 years since the listing of our first FTSE China A50 Index product - CSOP FTSE China A50 ETF (2822.HK) in 2012. Built on the success of 2822.HK, CSOP has begun our exciting journey of becoming an Asian ETF leader. Currently, CSOP has led Hong Kong ETF market with 7 out of 20 most traded ETF being from CSOP.
4 In addition, CSOP dominated HK L&I market with more than 96% and 90% market shares in terms of average daily turnover and asset under management respectively.
5 Today I am very glad to introduce another FTSE China A50 Index tracking products – 7248.HK and 7348.HK to the market and sincerely hope the FTSE China A50 Index L&I product can mark a development milestone of CSOP.”
About CSOP Asset Management LimitedCSOP Asset Management Limited (“CSOP”) was founded in 2008 as the first offshore asset manager set up by a regulated asset management company in China. With a dedicated focus on China investing, CSOP manages public and private funds, as well as providing investment advisory services to Asian and global investors. In addition, CSOP is best known as an ETF leader in Asia. As of 30 September 2020, CSOP had USD 8.9 billion in assets under management.
This material has not been reviewed by the Securities and Futures Commission.
Issuer: CSOP Asset Management Limited
Please refer to the offering documents for the index provider disclaimer.
IMPORTANT: Investment involves risks. Investment value may rise or fall. Past performance information presented is not indicative of future performance. Investors should refer to the Prospectus and the Product Key Facts Statement for further details, including product features and risk factors. Investors should not base on this material alone to make investment decisions.CSOP FTSE China A50 Index Daily (2x) Leveraged Product and CSOP FTSE China A50 Index Daily (-1x) Inverse Product (each, the “Product” or collectively, “Products”) are sub-funds of CSOP Leveraged and Inverse Series II, an umbrella unit trust established under Hong Kong law. Units of the Products (the “Units”) are traded in HKD on The Stock Exchange of Hong Kong Limited (the “SEHK”) like stocks. The Products use a swap-based synthetic replication strategy by investing directly in Swaps, so as to give the Product twice (2x) / inverse (-1x) of the Daily performance of the FTSE China A50 Index (the “Index”) respectively.
Please note that the above listed investment risks are not exhaustive and investors should read the Prospectus and Product Key Facts Statement in detail before making any investment decision.
1 Bloomberg: CSOP’s leveraged and inverse products AUM on 31 December, 2020, and average daily turnover for 2020
2 Bloomberg: as of 31 December, 2020
3 Bloomberg: the active contract for FTSE China A50 futures listed on SGX in 2020
4 Bloomberg: Hong Kong ETF market average daily turnover ranking for 2020
5 Bloomberg: HK L&I market average daily turnover for 2020 and asset under management as of 31 December, 2020 respectively
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210118005562/en/ContactFor further information, please contact
CSOP Asset Management Limited
Larry Wang / 3406 5613 /
larry.wang@csopasset.comTina Shu/ 3406 5675/
tina.shu@csopasset.comSource : CSOP Asset Management Limited
--BERNAMA